Hillel Bachrach is the Managing Partner and founder of 20/20 HealthCare Partners. See sector focus and contact routes.
Hillel Bachrach is the Managing Partner and founder of 20/20 HealthCare Partners, a global investment entity he established in 2005, with over 40 years of experience launching and exiting lifescience technologies. His firm invests across med-tech, diagnostic imaging hardware and software, healthcare IT (HCIT), and increasingly in advanced bio-technology and AI, targeting growth businesses, public offerings, buyouts, and re-capitalizations globally. While specific check sizes and lead/follow behavior are not publicly detailed, 20/20 HCP provides both equity financing and board/advisory support to its targets. Notable portfolio companies include Viztek (acquired by Konica Minolta in 2015), Corindus Vascular Robotics (purchased by Siemens HealthCare in 2019), XR Health, SQZ Biotechnology, Verseau Therapies, and EnClear Therapies. Bachrach also serves on the boards of Zixi and Velocamp and previously led Odin Medical Technologies and founded UltraSPECT, Ltd.. He holds a BS in electrical engineering from Technion and an MBA from Kellogg, but no distinctive public writing or unique investment philosophy beyond his firm’s stated focus on lifescience innovation is docu
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Boston when building a target list.
Investors like Hillel Bachrach · Full investor directory · Investor access · Company funding database